
Q-Line Biotec SME IPO Subscription
ListedUpdated 29 May 2026, 9:15 AM IST· NSE SME
Q-Line Biotec SME IPO subscription closed on 25 May 2026 at 102.42x overall by shares. QIB demand came in at 123.94x, NII at 146.33x, and retail at 71.44x. See Retail, SHNI, and BHNI allotment chances in the table below.
Allotment date is 26 May 2026. Listing date on NSE and BSE is 29 May 2026.
Q-Line Biotec SME IPO Day-wise Subscription
Daily QIB, NII, Retail, and overall subscription as bids come in
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 21 May 2026 | 4.15x | 5.26x | 3.71x | 4.17x |
| Day 2 - 22 May 2026 | 5.19x | 15.62x | 10.07x | 9.87x |
| Day 3 - 25 May 2026 | 123.94x | 145.98x | 71.44x | 102.42x |
Q-Line Biotec SME IPO Allotment Chances
Retail, SHNI, and BHNI chances based on application subscription
Q-Line Biotec SME IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.
| Category | Subscription (Apps) | Allotment Chances |
|---|---|---|
| Retail (IND) | 71.44x | 1 in 71 |
| SHNI (Rs 2L to Rs 10L) | 75.08x | 1 in 75 |
| BHNI (above Rs 10L) | 62.95x | 1 in 63 |
Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.
Check the Q-Line Biotec SME IPO Allotment Status page from 26 May 2026 for your result.
Q-Line Biotec SME IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 343.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 40.75 Cr | Rs 5,050.24 Cr | 123.94x |
| FII | - | Rs 711.11 Cr | - |
| DFI | - | Rs 1,107.77 Cr | - |
| Mutual Funds | - | Rs 94.00 Cr | - |
| Other | - | Rs 3,137.37 Cr | - |
| NII | Rs 30.58 Cr | Rs 4,475.01 Cr | 146.33x |
| bNII (above Rs 10L) | Rs 20.39 Cr | Rs 3,645.72 Cr | 178.82x |
| Corporate | - | Rs 55.61 Cr | - |
| Individual | - | Rs 3,525.19 Cr | - |
| Other | - | Rs 64.92 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 10.19 Cr | Rs 829.29 Cr | 81.35x |
| Corporate | - | Rs 5.53 Cr | - |
| Individual | - | Rs 808.66 Cr | - |
| Other | - | Rs 15.11 Cr | - |
| IND | Rs 71.32 Cr | Rs 5,094.98 Cr | 71.44x |
| Total | Rs 142.65 Cr | Rs 14,620.22 Cr | 102.49x |
Q-Line Biotec SME IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 2,970 | 197 | 0.07x |
| FII | - | 36 | - |
| DFI | - | 29 | - |
| Mutual Funds | - | 3 | - |
| Other | - | 129 | - |
| NII | 743 | 49,781 | 67.00x |
| bNII (above Rs 10L) | 495 | 31,162 | 62.95x |
| Corporate | - | 357 | - |
| Individual | - | 30,416 | - |
| Other | - | 389 | - |
| sNII (Rs 2L to Rs 10L) | 248 | 18,619 | 75.08x |
| Corporate | - | 133 | - |
| Individual | - | 18,154 | - |
| Other | - | 332 | - |
| IND | 2,599 | 1,85,677 | 71.44x |
| Total | 6,312 | 2,35,655 | 37.33x |
What Do These Subscription Numbers Mean?
102.42x overall by shares means bids covered about 102 times the shares on offer. Allotment chances depend on applications in each category.
QIB at 123.94x by shares shows institutional demand from mutual funds, FIIs, and banks.
NII covers bids above Rs 2 lakh (67.00x by applications). Split: SHNI 75.08x, BHNI 62.95x by applications. SHNI and BHNI allotment is by lottery.
At 71.44x subscription by applications, about 1 in 71 retail applicants may get allotment (~1% chance per application). Retail allotment is also by lottery.
Q-Line Biotec SME IPO GMP After Subscription
GMP for Q-Line Biotec SME stands at Rs 129.00 today, giving an estimated listing price of Rs 472.00 per share.
A subscription of 102.42x combined with a GMP of 37.61% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the Q-Line Biotec SME IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Q-Line Biotec SME IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 21 May 2026 |
| IPO Close Date | 25 May 2026 |
| Allotment Date | 26 May 2026 |
| Refund Initiation | 27 May 2026 |
| Share Credit to Demat | 27 May 2026 |
| Listing Date | 29 May 2026 |
| Minimum Investment | Rs 2,74,400.00 |
| Lot Size | 400 shares |
About Q-Line Biotec SME
Q-Line Biotech Limited, incorporated in 2010 (originally as POCT Services Private Limited), is an Indian diagnostics and in-vitro diagnostics (IVD) enterprise. The company is actively engaged in developing, manufacturing, and marketing a diverse range of medical reagents, consumable testing kits, point-of-care (POC) devices, and automated pathology equipment. Serving diagnostic laboratories, hospitals, and medical colleges directly and through an expansive national distributor network since 2013, its operational capabilities span fields like Clinical Chemistry, Haematology, Immunodiagnostics, and Molecular Diagnostics.
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors (SHNI & BHNI)
Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.
IND - Individual Investors
Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.
Q-Line Biotec SME IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Q-Line Biotec SME Details
Issue size, price, financials, and company info
Q-Line Biotec SME GMP
Live grey market premium and listing estimate
Q-Line Biotec SME Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Q-Line Biotec SME Allotment
Allotment date, chances, and check by PAN
Q-Line Biotec SME Review
SWOT, strengths, risks, and IPO review
Q-Line Biotec SME FAQ
Common questions on dates, GMP, and allotment
Q-Line Biotec SME Registrar
Registrar website and how to check allotment
Q-Line Biotec SME Timeline
Open, close, allotment, and listing dates
Q-Line Biotec SME News
Updates, blogs, and latest IPO news
Q-Line Biotec SME IPO Subscription FAQs
What is Q-Line Biotec SME IPO subscription status today?
Q-Line Biotec SME IPO subscription closed on 25 May 2026 with overall subscription of 102.42x (by shares) as of 17 August 2026, 1:32 PM IST. QIB 123.94x, NII 67.00x, IND 71.44x.
What is the overall subscription of Q-Line Biotec SME IPO?
Q-Line Biotec SME IPO is subscribed 102.42x overall by shares at close on 25 May 2026. QIB 123.94x, NII 67.00x, and IND 71.44x.
What is Q-Line Biotec SME IPO QIB subscription?
Q-Line Biotec SME IPO QIB (Qualified Institutional Buyers) subscription is 123.94x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Q-Line Biotec SME IPO IND subscription?
Q-Line Biotec SME IPO IND subscription is 71.44x by applications. Retail bids are up to Rs 2 lakh per PAN.
What is Q-Line Biotec SME IPO NII, SHNI, and BHNI subscription?
Q-Line Biotec SME IPO NII subscription is 67.00x by applications. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) at 75.08x and BHNI (above Rs 10L) at 62.95x.
What are Q-Line Biotec SME IPO retail allotment chances?
At 71.44x subscription by applications, about 1 in 71 retail applicants may get allotment (~1% chance per application). Allotment is by lottery.
What are Q-Line Biotec SME IPO SHNI allotment chances?
At 75.08x subscription by applications, about 1 in 75 SHNI applicants may get allotment (~1% chance per application). Allotment is by lottery. Share subscription was 81.35x. Allotment chances use applications, not share volume.
What are Q-Line Biotec SME IPO BHNI allotment chances?
At 62.95x subscription by applications, about 1 in 63 BHNI applicants may get allotment (~2% chance per application). Allotment is by lottery. Share subscription was 178.82x. Allotment chances use applications, not share volume.
When is Q-Line Biotec SME IPO allotment date?
Q-Line Biotec SME IPO allotment date is 26 May 2026. Check Q-Line Biotec SME IPO Allotment Status on IPOwiz from that day using your PAN.
When does Q-Line Biotec SME IPO subscription close?
Q-Line Biotec SME IPO subscription closed on 25 May 2026. No new applications are accepted after the close.
What is Q-Line Biotec SME IPO GMP today?
Q-Line Biotec SME IPO GMP is ₹129 today (+37.61% over issue price ₹343). See live GMP on the Q-Line Biotec SME IPO GMP Today page.
What is Q-Line Biotec SME IPO issue price and lot size?
Q-Line Biotec SME IPO issue price is ₹343 per share. Lot size is 400 shares. Minimum investment is ₹2,74,400 per lot (minimum 2 lots for SME). Issue size: ₹214.48 Cr.
When is Q-Line Biotec SME IPO listing date?
Q-Line Biotec SME IPO listing date is 29 May 2026 on NSE and BSE. Allotment is on 26 May 2026.
How does subscription affect Q-Line Biotec SME IPO allotment?
In Q-Line Biotec SME IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 102.42x overall, competition is very high.
For allotment results from 26 May 2026, visit the Q-Line Biotec SME IPO Allotment Status page. For listing day updates on 29 May 2026, download the IPOwiz App.
Sources
We match Q-Line Biotec SME IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, and How allotment chances work.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.